US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist
  • 70.510
  • -1.280-1.78%
Close May 1 16:00 ET
  • 70.650
  • +0.140+0.20%
Post 20:01 ET
218.61BMarket Cap28.37P/E (TTM)

AstraZeneca Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
7.17%13.59B
18.03%54.07B
23.84%14.89B
18.04%13.57B
13.33%12.94B
16.55%12.68B
3.29%45.81B
7.29%12.02B
4.64%11.49B
5.99%11.42B
Operating revenue
7.17%13.59B
18.03%54.07B
23.84%14.89B
18.04%13.57B
13.33%12.94B
16.55%12.68B
3.29%45.81B
7.29%12.02B
4.64%11.49B
5.99%11.42B
Cost of revenue
1.04%2.24B
23.45%10.21B
18.07%2.73B
47.06%3.08B
11.38%2.18B
16.43%2.22B
-33.27%8.27B
-20.41%2.31B
-29.75%2.1B
-34.62%1.96B
Gross profit
8.47%11.35B
16.84%43.87B
25.22%12.17B
11.57%10.48B
13.74%10.76B
16.57%10.46B
17.47%37.54B
16.96%9.72B
17.46%9.4B
21.65%9.46B
Operating expense
4.45%7.67B
16.63%33.62B
19.43%10.13B
12.56%8.38B
14.41%8.01B
10.20%7.35B
5.00%28.82B
32.59%8.48B
10.19%7.44B
-3.23%7B
Selling and administrative expenses
-0.06%4.63B
10.99%20.22B
0.67%5.55B
7.28%5.29B
-1.09%5.06B
10.42%4.63B
1.32%18.22B
44.93%5.52B
11.95%4.93B
6.38%5.12B
-Selling and marketing expense
0.00%135M
2.97%555M
-1.38%143M
12.40%145M
0.76%132M
0.75%135M
0.56%539M
-7.05%145M
2.38%129M
1.55%131M
-General and administrative expense
-0.07%4.49B
11.23%19.67B
0.73%5.41B
7.15%5.14B
-1.14%4.93B
10.74%4.5B
1.35%17.68B
47.15%5.37B
12.23%4.8B
6.52%4.99B
Research and development costs
13.51%3.16B
24.22%13.58B
52.20%4.68B
20.55%3.12B
12.79%3.01B
6.59%2.78B
12.02%10.94B
17.07%3.07B
5.13%2.58B
4.75%2.67B
Other operating expenses
----
-26.22%121M
----
----
----
----
-18.00%164M
----
----
----
Operating profit
17.95%3.67B
17.53%10.25B
64.99%2.04B
7.78%2.11B
11.81%2.75B
34.97%3.12B
93.31%8.72B
-35.39%1.23B
56.95%1.95B
355.66%2.46B
Net non-operating interest income expense
12.25%-265M
-3.80%-1.34B
-8.31%-365M
5.84%-274M
6.54%-343M
-5.23%-302M
-3.12%-1.29B
-7.67%-337M
10.19%-291M
-25.26%-367M
Non-operating interest income
-24.32%84M
14.62%345M
-40.74%64M
81.19%183M
56.25%100M
42.31%111M
271.60%301M
248.39%108M
573.33%101M
255.56%64M
Non-operating interest expense
-15.50%349M
5.85%1.68B
-3.60%429M
16.58%457M
2.78%443M
13.15%413M
19.47%1.59B
29.36%445M
15.63%392M
38.59%431M
Other net income (expense)
Special income (charges)
----
53.12%-248M
----
----
----
--0
29.93%-529M
----
----
----
-Less:Restructuring and merger&acquisition
----
-50.00%260M
----
----
----
----
185.71%520M
----
----
----
-Less:Other special charges
----
-233.33%-12M
----
----
----
----
-98.43%9M
----
----
----
Income before tax
21.50%3.4B
25.97%8.69B
85.73%1.67B
10.65%1.83B
14.80%2.4B
23.78%2.8B
175.85%6.9B
15.30%897M
79.18%1.65B
745.34%2.09B
Income tax
-22.42%481M
75.91%1.65B
367.74%166M
44.16%395M
75.00%469M
35.37%620M
218.43%938M
50.00%-62M
138.06%274M
337.17%268M
Net income
33.99%2.92B
18.12%7.04B
56.41%1.5B
3.99%1.43B
5.93%1.93B
20.84%2.18B
81.02%5.96B
6.32%959M
-16.08%1.38B
405.56%1.82B
Net income continuous Operations
33.99%2.92B
18.12%7.04B
56.41%1.5B
3.99%1.43B
5.93%1.93B
20.84%2.18B
81.02%5.96B
6.32%959M
-16.08%1.38B
405.56%1.82B
Minority interest income
400.00%5M
0.00%6M
0
0.00%4M
-50.00%1M
0.00%1M
20.00%6M
-200.00%-1M
100.00%4M
2M
Net income attributable to the parent company
33.82%2.92B
18.14%7.04B
56.25%1.5B
4.00%1.43B
6.00%1.93B
20.85%2.18B
81.11%5.96B
6.55%960M
-16.22%1.37B
405.00%1.82B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
33.82%2.92B
18.14%7.04B
56.25%1.5B
4.00%1.43B
6.00%1.93B
20.85%2.18B
81.11%5.96B
6.55%960M
-16.22%1.37B
405.00%1.82B
Basic earnings per share
33.33%0.94
18.23%2.27
56.45%0.485
3.37%0.46
5.98%0.62
21.55%0.705
81.13%1.92
6.90%0.31
-16.04%0.445
408.70%0.585
Diluted earnings per share
33.57%0.935
18.11%2.25
54.84%0.48
3.41%0.455
5.98%0.62
20.69%0.7
80.57%1.905
6.90%0.31
-16.19%0.44
408.70%0.585
Dividend per share
6.60%1.05
2.41%1.485
0
7.53%0.5
0
0.00%0.985
0.00%1.45
0
0.00%0.465
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 7.17%13.59B18.03%54.07B23.84%14.89B18.04%13.57B13.33%12.94B16.55%12.68B3.29%45.81B7.29%12.02B4.64%11.49B5.99%11.42B
Operating revenue 7.17%13.59B18.03%54.07B23.84%14.89B18.04%13.57B13.33%12.94B16.55%12.68B3.29%45.81B7.29%12.02B4.64%11.49B5.99%11.42B
Cost of revenue 1.04%2.24B23.45%10.21B18.07%2.73B47.06%3.08B11.38%2.18B16.43%2.22B-33.27%8.27B-20.41%2.31B-29.75%2.1B-34.62%1.96B
Gross profit 8.47%11.35B16.84%43.87B25.22%12.17B11.57%10.48B13.74%10.76B16.57%10.46B17.47%37.54B16.96%9.72B17.46%9.4B21.65%9.46B
Operating expense 4.45%7.67B16.63%33.62B19.43%10.13B12.56%8.38B14.41%8.01B10.20%7.35B5.00%28.82B32.59%8.48B10.19%7.44B-3.23%7B
Selling and administrative expenses -0.06%4.63B10.99%20.22B0.67%5.55B7.28%5.29B-1.09%5.06B10.42%4.63B1.32%18.22B44.93%5.52B11.95%4.93B6.38%5.12B
-Selling and marketing expense 0.00%135M2.97%555M-1.38%143M12.40%145M0.76%132M0.75%135M0.56%539M-7.05%145M2.38%129M1.55%131M
-General and administrative expense -0.07%4.49B11.23%19.67B0.73%5.41B7.15%5.14B-1.14%4.93B10.74%4.5B1.35%17.68B47.15%5.37B12.23%4.8B6.52%4.99B
Research and development costs 13.51%3.16B24.22%13.58B52.20%4.68B20.55%3.12B12.79%3.01B6.59%2.78B12.02%10.94B17.07%3.07B5.13%2.58B4.75%2.67B
Other operating expenses -----26.22%121M-----------------18.00%164M------------
Operating profit 17.95%3.67B17.53%10.25B64.99%2.04B7.78%2.11B11.81%2.75B34.97%3.12B93.31%8.72B-35.39%1.23B56.95%1.95B355.66%2.46B
Net non-operating interest income expense 12.25%-265M-3.80%-1.34B-8.31%-365M5.84%-274M6.54%-343M-5.23%-302M-3.12%-1.29B-7.67%-337M10.19%-291M-25.26%-367M
Non-operating interest income -24.32%84M14.62%345M-40.74%64M81.19%183M56.25%100M42.31%111M271.60%301M248.39%108M573.33%101M255.56%64M
Non-operating interest expense -15.50%349M5.85%1.68B-3.60%429M16.58%457M2.78%443M13.15%413M19.47%1.59B29.36%445M15.63%392M38.59%431M
Other net income (expense)
Special income (charges) ----53.12%-248M--------------029.93%-529M------------
-Less:Restructuring and merger&acquisition -----50.00%260M----------------185.71%520M------------
-Less:Other special charges -----233.33%-12M-----------------98.43%9M------------
Income before tax 21.50%3.4B25.97%8.69B85.73%1.67B10.65%1.83B14.80%2.4B23.78%2.8B175.85%6.9B15.30%897M79.18%1.65B745.34%2.09B
Income tax -22.42%481M75.91%1.65B367.74%166M44.16%395M75.00%469M35.37%620M218.43%938M50.00%-62M138.06%274M337.17%268M
Net income 33.99%2.92B18.12%7.04B56.41%1.5B3.99%1.43B5.93%1.93B20.84%2.18B81.02%5.96B6.32%959M-16.08%1.38B405.56%1.82B
Net income continuous Operations 33.99%2.92B18.12%7.04B56.41%1.5B3.99%1.43B5.93%1.93B20.84%2.18B81.02%5.96B6.32%959M-16.08%1.38B405.56%1.82B
Minority interest income 400.00%5M0.00%6M00.00%4M-50.00%1M0.00%1M20.00%6M-200.00%-1M100.00%4M2M
Net income attributable to the parent company 33.82%2.92B18.14%7.04B56.25%1.5B4.00%1.43B6.00%1.93B20.85%2.18B81.11%5.96B6.55%960M-16.22%1.37B405.00%1.82B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 33.82%2.92B18.14%7.04B56.25%1.5B4.00%1.43B6.00%1.93B20.85%2.18B81.11%5.96B6.55%960M-16.22%1.37B405.00%1.82B
Basic earnings per share 33.33%0.9418.23%2.2756.45%0.4853.37%0.465.98%0.6221.55%0.70581.13%1.926.90%0.31-16.04%0.445408.70%0.585
Diluted earnings per share 33.57%0.93518.11%2.2554.84%0.483.41%0.4555.98%0.6220.69%0.780.57%1.9056.90%0.31-16.19%0.44408.70%0.585
Dividend per share 6.60%1.052.41%1.48507.53%0.500.00%0.9850.00%1.4500.00%0.4650
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More